Heidi key facts
as of Oct 2026- Developer of a clinical training and decision support tool designed to practice clinical reasoning.
- Heidi is valued at approximately $703.0M as of Oct 2026 (last reported valuation).
- It has raised $129.6M; the latest was Later Stage VC ($98.0M) in Nov 2025.
- Notable investors include Alumni Ventures, Goodwater Capital, Menlo Ventures, Headline, Phoenix Court — 23 tracked in total.
- Status: Privately Held (backing).
Heidi's last reported valuation, Nov 2025. Nothing priced has surfaced since.
- ·The complete investor list: 23 names
- ·Watch Heidi: the Monday email on marks, rounds and moves
Heidi funding rounds
No funding rounds for Heidi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Heidi
23+Heidi valuation
Heidi's last reported valuation was $703 million in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.
Heidi investors
23 investors are on record for Heidi, including Alumni Ventures, Goodwater Capital, Menlo Ventures and Headline. By type, the record holds 12 venture capital firms and 1 corporate investor.
About Heidi
Developer of a clinical training and decision support tool designed to practice clinical reasoning. The company's tool provides real-time data collection for patient feedback and patients' diseases for diagnosis and facilitates the storage of collected data automatically, which can be viewed on the built-in dashboard, enabling medical professionals to learn and analyze patients' health to eliminate missed diagnoses.
- Sector
- Healthcare
- HQ
- Melbourne, NY, Australia
- Founded
- 2019
- Employees
- 200
- Website
- heidihealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.